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Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312S74Longitudinal variations of SF-ARGS and serum-ARGS are presented for
the six subjects that had samples available from all visits (Figure 1).
Conclusions: Levels of ARGS-aggrecan in synovial ﬂuid are increased
compared to knee-healthy individuals over the ﬁrst 16 weeks after ACL
injury, thereafter these levels seem to normalize with levels in synovial
ﬂuid being no different from that in uninjured, knee-healthy individ-
uals. Serum levels of ARGS-aggrecan display a temporal change after
trauma, although less pronounced than in SF.Figure 1. Longitudinal change in ARGS-aggrecan concentrations in synovial ﬂuid (SF)
and serum in six subjects with a complete set of samples from all visits.121
THE ANATOMICAL SITE OF SYNOVIAL FLUID SAMPLING FROM THE
OSTEOARTHRITIC KNEE: DOES IT MATTER?
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Purpose: End-stage anteromedial knee OA (AMOA) is associated with
limited lateral joint space narrowing osteophytosis or synovitis. Syno-
vial ﬂuid (SF) is a non-Newtonian biological ﬂuid with a complex non-
homogenous matrix. Despite the free ﬂow of SF within the knee, this
raises the possibility of compartment-speciﬁc SF biology. Equilibrium in
SF composition between knee joint compartments is assumed, but has
never been formally tested. Anatomical variations in SF analysis would
have important practical implications for the consistency of sampling
needed for biomarker research, especially for unicompartmental OA.
This study aims to determine if the anatomical site of sampling affects
SF analysis in patients with end-stage AMOA and tri-compartmental OA
(TCOA).
Methods: SF was collected from the medial, lateral and patello-femoral
(PF) compartments of patients with AMOA (n¼8) and TCOA (n¼8) at the
time of primary arthroplasty (total N¼16). Site-speciﬁc SF collection
(w250ml/compartment) was done simultaneously prior to arthrotomy.
Samples underwent identical processing, storage and preparation.
Samples were analysed for 9 pro-inﬂammatory cytokines (IL1b, TNFa,
IL6, IL8, IL15, IL2, IL12, IL17 & GMCSF), 4 regulatory cytokines (IL1RA, IL4,
IL10, IL2R), 7 chemokines (Eotaxin, IP10, MCP1, MIG, MIP1a, MIP1b,
RANTES) and TGFb1, -b2 & -b3. Each of the three joint compartments
was given a Kellgren & Lawrence grade (KLG), and the OARSI systemwas
applied to the medial and lateral compartments only as originallydescribed. Within-subject comparisons of KLG and OARSI scores for
joint space narrowing (JSN) and osteophytosis (OP) between joint
compartments were conducted separately for patients with AMOA and
TCOA. P<0.05 was considered statistically signiﬁcant. The agreement of
SF measurements between compartments was assessed for each ana-
lyte using the coefﬁcient of variation (CV) and intraclass correlation
coefﬁcient (ICC). The acceptable threshold for cross-compartment CV
(cCV) was set at 20%, which is the threshold for acceptable intra- and
inter-assay precision. An ICC >0.80 was considered excellent absolute
agreement.
Results: Compartment KLG (p<0.001), OARSI JNS (p¼0.012) and OARSI
OP (p¼0.030) scores for AMOA were signiﬁcantly higher in the medial
compartment, but there was no signiﬁcant difference between sites for
TCOA. In both AMOA and TCOA patients, only 10 analytes were quan-
tiﬁable in 75% (6/8) of compartment-matched samples to allow
meaningful analysis: 4 pro-inﬂammatory cytokines (IL6, IL8, IL12 &
IL15); 3 chemokines (Eotaxin, MCP1 & IP10); and the 3 isoforms of TGFb.
The median cCV for all analytes was <15% in both AMOA and TCOA
patient groups. The median cCV was signiﬁcantly less than 20% (one
sample Wilcoxon signed rank test) for all analytes in both patient
groups. The ICC for absolute agreement was>0.80 for all analytes in the
both patient groups. Seven (out of 10) analytes had ICCs >0.90 in both
groups.
Conclusions: There is excellent agreement between compartment-
speciﬁc SF measurements in both AMOA and TCOA. The anatomical site
of sampling does not affect SF analysis even when there are signiﬁcant
compartmental differences in structural burden of disease. The ﬁndings
strongly suggest biological equilibrium in SF composition between joint
compartments in end-stage knee OA. Consequently, the anatomical site
of SF collection is not an important practical implication for biomarker
research in knee OA.122
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Purpose: A disintegrin and metalloproteinase with thrombospondin
motifs 4 (ADAMTS-4, aggrecanase1) and matrix metalloproteinase 9
(MMP-9, Gelatinase B) are believed two of the main drivers in the
degradation of cartilage in osteoarthritis (OA). Both ADAMTS-4 and
MMP-9 are synthesized as latent pro-enzymes that require the removal
of the pro-domain, exposing the N-terminal neoepitope, to achieve
activity. We developed monoclonal antibodies against the neoepitopes
of active ADAMTS-4 and MMP-9 to investigate the distribution of pro-
teolytical activity in cartilage of OA patients.
Methods: We established and characterized a competitive ELISAs
for measuring the active forms of ADAMTS-4 and MMP-9 speciﬁ-
cally. Speciﬁcity of the antibodies was tested by ELISAs and western
blot, using synthetic peptides and pro- and latent puriﬁed prote-
ases. We used these assay to proﬁle proteolytical activity and their
aggrecan (AGNx-1, AGNx-2) and type II collagen degradation
products (C2M) in a bovine cartilage ex vivo model (21 days). The
location of the proteolytical activity in human OA patients (n¼20)
was investigated by immunohistochemistry using the speciﬁc
antibodies. Safranin O (proteoglycans) and fast green (collagens)
staining and scored according to modiﬁed Mankin were done on
adjacent sections.
Results: We found that after stimulation with catabolic factors, the
cartilage initially (day 3 to 10) released high levels of aggrecanase-
derived aggrecan fragments (AGNx-1) into supernatant, but subse-
quently decreased to background levels. MMP-derived aggrecan and
type II collagen fragments (AGNx-2, C2M) were released delayed (day
15 to 21) compared to AGNx-2. Whereas active ADAMTS-4 was
retained in the cartilage and released into the supernatant continu-
ously throughout the 21 days, active MMP-9 was only observed in the
second half of the culture period. Samples of human OA cartilage
affected by varying degrees of osteoarthritis stained strongly for
